Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

132 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Management of non-metastatic anal cancer in the elderly: ancillary study of the French multicenter prospective cohort FFCD-ANABASE.
Gouriou C, Lemanski C, Pommier P, Le Malicot K, Saint A, Rivin Del Campo E, Evin C, Quero L, Regnault P, Baba-Hamed N, Ronchin P, Crehange G, Tougeron D, Menager-Tabourel E, Diaz O, Hummelsberger M, de la Rocherfordiere A, Drouet F, Vendrely V, Lièvre A. Gouriou C, et al. Among authors: quero l. Br J Cancer. 2024 Mar;130(5):769-776. doi: 10.1038/s41416-023-02564-9. Br J Cancer. 2024. PMID: 38184691
Exclusive moderate-dose radiotherapy in gastric marginal zone B-cell MALT lymphoma: Results of a prospective study with a long term follow-up.
Ruskoné-Fourmestraux A, Matysiak-Budnik T, Fabiani B, Cervera P, Brixi H, Le Malicot K, Nion-Larmurier I, Fléjou JF, Hennequin C, Quéro L; Groupe d’Étude des Lymphomes Digestifs (GELD) & Fédération Francophone de Cancérologie Digestive. Ruskoné-Fourmestraux A, et al. Among authors: quero l. Radiother Oncol. 2015 Oct;117(1):178-82. doi: 10.1016/j.radonc.2015.08.029. Epub 2015 Sep 20. Radiother Oncol. 2015. PMID: 26395311 Review.
Efficacy and Safety of Two Neoadjuvant Strategies With Bevacizumab in MRI-Defined Locally Advanced T3 Resectable Rectal Cancer: Final Results of a Randomized, Noncomparative Phase 2 INOVA Study.
Borg C, Mantion G, Boudghène F, Mornex F, Ghiringhelli F, Adenis A, Azria D, Balosso J, Ben Abdelghani M, Bachet JB, Vendrely V, François Y, Conroy T, Rio E, Roullet B, Spaëth D, Quero L, Lakkis Z, Coudert M, Ionescu-Goga M, Tanang A, André T. Borg C, et al. Among authors: quero l. Clin Colorectal Cancer. 2019 Sep;18(3):200-208.e1. doi: 10.1016/j.clcc.2019.04.006. Epub 2019 May 3. Clin Colorectal Cancer. 2019. PMID: 31311761 Clinical Trial.
[Definitive or neo-adjuvant chemoradiation in esophageal carcinoma?].
Modesto A, Carrère N, Guimbaud R, Rives M, Deutsch É, Quéro L, Créhange G. Modesto A, et al. Among authors: quero l. Cancer Radiother. 2019 Oct;23(6-7):716-719. doi: 10.1016/j.canrad.2019.06.010. Epub 2019 Aug 14. Cancer Radiother. 2019. PMID: 31421997 Review. French.
What is the optimal treatment for T1N0 anal squamous cell carcinoma? Analysis of current practices in the prospective French FFCD ANABASE cohort.
Bacci M, Quero L, Barbier E, Parrot L, Juguet F, Pommier P, Bazire L, Etienney I, Baba-Hamed N, Spindler L, François E, Ronchin P, Campo ERD, Lemanski C, Lièvre A, Siproudhis L, Abramowitz L, Lepage C, Vendrely V. Bacci M, et al. Among authors: quero l. Dig Liver Dis. 2021 Jun;53(6):776-784. doi: 10.1016/j.dld.2021.03.015. Epub 2021 Apr 16. Dig Liver Dis. 2021. PMID: 33867291
Locoregional relapses in the ACCORD 12/0405-PRODIGE 02 study: Dosimetric study and risk factors.
Meillan N, Orthuon A, Chauchat P, Atlani D, Bouche O, Chaulin B, David C, Deberne M, Debrigode C, Kao W, Keller A, Laharie H, Lamezec B, Lemanski C, Magné N, Mahé MA, Mere P, Moureau-Zabotto L, Peiffert D, Pointreau Y, Quéro L, Racadot S, Roca S, Sargos P, Servagi S, Tang E, Vendrely V, Doyen J, Huguet F. Meillan N, et al. Among authors: quero l. Radiother Oncol. 2021 Aug;161:198-204. doi: 10.1016/j.radonc.2021.06.006. Epub 2021 Jun 16. Radiother Oncol. 2021. PMID: 34144078
Radiotherapy for cancers of the oesophagus, cardia and stomach.
Créhange G, Modesto A, Vendrely V, Quéro L, Mirabel X, Rétif P, Huguet F. Créhange G, et al. Among authors: quero l. Cancer Radiother. 2022 Feb-Apr;26(1-2):250-258. doi: 10.1016/j.canrad.2021.11.022. Epub 2021 Dec 23. Cancer Radiother. 2022. PMID: 34955417
132 results